You are here

  • Home
  • Archive
  • Volume 6, Issue 1
  • Complete intracranial response to talimogene laherparepvec (T-Vec), pembrolizumab and whole brain radiotherapy in a patient with melanoma brain metastases refractory to dual checkpoint-inhibition

Article metrics

Article menu

Download PDFPDF

Case Report
Complete intracranial response to talimogene laherparepvec (T-Vec), pembrolizumab and whole brain radiotherapy in a patient with melanoma brain metastases refractory to dual checkpoint-inhibition

 

Online download statistics by month:

Online download statistics by month: December 2019 to March 2024

AbstractFullPdf
Dec 2019220
Jan 202010101
Feb 2020242414
Mar 202033335
Apr 202017170
May 202036369
Jun 202033333
Jul 202027274
Aug 202027276
Sep 202036365
Oct 202033331
Nov 202013142
Dec 202021218
Jan 202118183
Feb 202112125
Mar 202123228
Apr 2021232310
May 202120204
Jun 202121212
Jul 202116162
Aug 202116164
Sep 202123234
Oct 202120208
Nov 202121212
Dec 202115162
Jan 202221224
Feb 202213132
Mar 202214153
Apr 202226274
May 202229292
Jun 202220202
Jul 202253553
Aug 202240402
Sep 202228297
Oct 202217215
Nov 2022212315
Dec 202213135
Jan 202323237
Feb 202326281
Mar 202312133
Apr 202318196
May 202315166
Jun 202313131
Jul 202312129
Aug 202318182
Sep 202315173
Oct 202311111
Nov 202316168
Dec 202322225
Jan 202428297
Feb 202420206
Mar 202420208
Total11041125239